{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T04:38:24Z","timestamp":1725943104412},"reference-count":20,"publisher":"Spandidos Publications","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncol Lett"],"DOI":"10.3892\/ol.2018.8959","type":"journal-article","created":{"date-parts":[[2018,6,12]],"date-time":"2018-06-12T12:55:50Z","timestamp":1528808150000},"source":"Crossref","is-referenced-by-count":3,"title":["Correlation of CT signs with lymphatic metastasis and pathology of neuroblastoma in children"],"prefix":"10.3892","author":[{"given":"Xinxian","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Radiology, Xuzhou Children's Hospital, Xuzhou, Jiangsu 221000, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chenglong","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Radiology, Xuzhou Children's Hospital, Xuzhou, Jiangsu 221000, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Radiology, Xuzhou Children's Hospital, Xuzhou, Jiangsu 221000, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangdong","family":"Hao","sequence":"additional","affiliation":[{"name":"Department of Radiology, Xuzhou Children's Hospital, Xuzhou, Jiangsu 221000, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Radiology, Xuzhou Children's Hospital, Xuzhou, Jiangsu 221000, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiancheng","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Radiology, Xuzhou Children's Hospital, Xuzhou, Jiangsu 221000, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2018,6,12]]},"reference":[{"key":"key20200714083242_b1-ol-0-0-8959","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.pcl.2014.09.015","article-title":"Neuroblastoma: Paradigm for precision medicine","volume":"62","author":"Irwin","year":"2015","journal-title":"Pediatr Clin North Am"},{"key":"key20200714083242_b2-ol-0-0-8959","doi-asserted-by":"publisher","first-page":"3008","DOI":"10.1200\/JCO.2014.59.4648","article-title":"Advances in risk classification and treatment strategies for neuroblastoma","volume":"33","author":"Pinto","year":"2015","journal-title":"J Clin Oncol"},{"key":"key20200714083242_b3-ol-0-0-8959","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1038\/nature14980","article-title":"Telomerase activation by genomic rearrangements in high-risk neuroblastoma","volume":"526","author":"Peifer","year":"2015","journal-title":"Nature"},{"key":"key20200714083242_b4-ol-0-0-8959","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1002\/pbc.25385","article-title":"Pediatric reference intervals for plasma free and total metanephrines established with a parametric approach: Relevance to the diagnosis of neuroblastoma","volume":"62","author":"Franscini","year":"2015","journal-title":"Pediatr Blood Cancer"},{"key":"key20200714083242_b5-ol-0-0-8959","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1002\/ijc.30482","article-title":"The incidence and mortality rates of neuroblastoma cases before and after the cessation of the mass screening program in Japan: A descriptive study","volume":"140","author":"Shinagawa","year":"2016","journal-title":"Int J Cancer"},{"key":"key20200714083242_b6-ol-0-0-8959","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1056\/NEJMoa1510795","article-title":"Reduction in late mortality among 5-Year survivors of childhood cancer","volume":"374","author":"Armstrong","year":"2016","journal-title":"N Engl J Med"},{"key":"key20200714083242_b7-ol-0-0-8959","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1007\/s11307-014-0783-7","article-title":"Patient-specific dosimetry using pretherapy [124I]m-iodobenzylguanidine ([124I]mIBG) dynamic PET\/CT imaging before [131I]mIBG targeted radionuclide therapy for neuroblastoma","volume":"17","author":"Huang","year":"2015","journal-title":"Mol Imaging Biol"},{"key":"key20200714083242_b8-ol-0-0-8959","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1097\/MPH.0000000000000411","article-title":"Initial experience with gallium-68 DOTA-octreotate PET\/CT and peptide receptor radionuclide therapy for pediatric patients with refractory metastatic neuroblastoma","volume":"38","author":"Kong","year":"2016","journal-title":"J Pediatr Hematol Oncol"},{"key":"key20200714083242_b9-ol-0-0-8959","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1146\/annurev-med-011514-023121","article-title":"Neuroblastoma: Molecular pathogenesis and therapy","volume":"66","author":"Louis","year":"2015","journal-title":"Annu Rev Med"},{"key":"key20200714083242_b10-ol-0-0-8959","doi-asserted-by":"publisher","first-page":"4155","DOI":"10.18632\/oncotarget.6393","article-title":"Lack of survival advantage with autologous stem-cell transplantation in high-risk neuroblastoma consolidated by anti-GD2 immunotherapy and isotretinoin","volume":"7","author":"Kushner","year":"2016","journal-title":"Oncotarget"},{"key":"key20200714083242_b11-ol-0-0-8959","doi-asserted-by":"publisher","first-page":"4597","DOI":"10.1007\/s12035-016-0009-x","article-title":"Tanshinone I induces mitochondrial protection through an Nrf2-dependent mechanism in paraquat-treated human neuroblastoma SH-SY5Y cells","volume":"54","author":"de Oliveira","year":"2017","journal-title":"Mol Neurobiol"},{"key":"key20200714083242_b12-ol-0-0-8959","doi-asserted-by":"publisher","first-page":"7610","DOI":"10.1007\/s12035-016-0250-3","article-title":"Combined treatments with a retinoid receptor agonist and epigenetic modulators in human neuroblastoma cells","volume":"54","author":"Almeida","year":"2017","journal-title":"Mol Neurobiol"},{"key":"key20200714083242_b13-ol-0-0-8959","doi-asserted-by":"publisher","first-page":"3839","DOI":"10.1038\/onc.2015.455","article-title":"Cell type-dependent ROS and mitophagy response leads to apoptosis or necroptosis in neuroblastoma","volume":"35","author":"Radogna","year":"2016","journal-title":"Oncogene"},{"key":"key20200714083242_b14-ol-0-0-8959","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1158\/1078-0432.CCR-15-0379","article-title":"Crizotinib synergizes with chemotherapy in preclinical models of neuroblastoma","volume":"22","author":"Krytska","year":"2016","journal-title":"Clin Cancer Res"},{"key":"key20200714083242_b15-ol-0-0-8959","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12929-017-0319-y","article-title":"Neuroblastoma treatment in the post-genomic era","volume":"24","author":"Esposito","year":"2017","journal-title":"J Biomed Sci"},{"key":"key20200714083242_b16-ol-0-0-8959","first-page":"153","article-title":"Novel targeted treatment combinations for malignant neuroendocrine tumour olfactory neuroblastoma","volume":"38","author":"Young","year":"2015","journal-title":"Endoc Abstr"},{"key":"key20200714083242_b17-ol-0-0-8959","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.etp.2016.02.001","article-title":"Treatment with the neurotoxic A\u03b2 (25\u201335) peptide modulates the expression of neuroprotective factors Pin1, Sirtuin 1, and brain-derived neurotrophic factor in SH-SY5Y human neuroblastoma cells","volume":"68","author":"Lattanzio","year":"2016","journal-title":"Exp Toxicol Pathol"},{"key":"key20200714083242_b18-ol-0-0-8959","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1097\/MNM.0000000000000470","article-title":"Individualized 131I-mIBG therapy in the management of refractory and relapsed neuroblastoma","volume":"37","author":"George","year":"2016","journal-title":"Nucl Med Commun"},{"key":"key20200714083242_b19-ol-0-0-8959","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1097\/MOP.0000000000000296","article-title":"Genetic discoveries and treatment advances in neuroblastoma","volume":"28","author":"Bagatell","year":"2016","journal-title":"Curr Opin Pediatr"},{"key":"key20200714083242_b20-ol-0-0-8959","doi-asserted-by":"publisher","first-page":"9271","DOI":"10.18632\/oncotarget.7005","article-title":"MicroRNA-497 impairs the growth of chemoresistant neuroblastoma cells by targeting cell cycle, survival and vascular permeability genes","volume":"7","author":"Soriano","year":"2016","journal-title":"Oncotarget"}],"container-title":["Oncology Letters"],"original-title":[],"deposited":{"date-parts":[[2020,7,14]],"date-time":"2020-07-14T09:00:59Z","timestamp":1594717259000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ol.2018.8959"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,12]]},"references-count":20,"URL":"https:\/\/doi.org\/10.3892\/ol.2018.8959","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,12]]}}}